Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-09-08 20:01:03 ET · period of report 2026-09-04 · accession 0001193125-26-385536 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-08 20:01 | 2026-09-04 | SRPT | Rodino-Klapac Louise | Pres, R, D, Tech Ops | F - Tax | $22.22 | -21.4K | 203.9K | -10% | -$476.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-04 | F | D | 21,423 | $22.22 | 203,900 | D | — | — | (F1) Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on September 3, 2025. |